SCHEMBL30852147

SCHEMBL30852147

CCc1cnc(N)c(C(=O)OC)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.44
MAPKAPK2 P49137 3/20 0.40
ATR Q13535 2/20 0.40
PRKCI P41743 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.38
DHFR P00374 1/20 0.38
KDM4E B2RXH2 5/20 0.37
ALDH1A1 P00352 4/20 0.37
HSD17B10 Q99714 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 3/20 0.37
GMNN O75496 1/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRG2 P18507 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19743909 1.00 NPSR1 (0.44) NPSR1MAPKAPK2ATRPRKCIL3MBTL1
SCHEMBL30852257 0.89 NPSR1 (0.42) NPSR1MAPKAPK2ATRPRKCIL3MBTL1
Lithium Ion SCHEMBL19743877 0.83 ATR (0.37) MAPKAPK2ATRPRKCIDHFRALDH1A1
SCHEMBL3868054 0.83 GABRP (0.41) MAPKAPK2ATRPRKCIDHFRGABRA1
SCHEMBL7456521 0.83 ACVR1 (0.40) NPSR1MAPKAPK2ATRL3MBTL1KDM4E
SCHEMBL25206722 0.82 NPSR1 (0.42) NPSR1L3MBTL1KDM4EALDH1A1HSD17B10
SCHEMBL25281688 0.81 NPSR1 (0.39) NPSR1MAPKAPK2ATRKDM4EALDH1A1
SCHEMBL19718220 0.79 NPSR1 (0.50) NPSR1ATRL3MBTL1KDM4EALDH1A1
SCHEMBL261742 0.77 ATR (0.54) NPSR1ATRL3MBTL1KDM4EALDH1A1
SCHEMBL262307 0.77 GRM5 (0.54) NPSR1ATRPRKCIL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4587014-A2 C5AR1 ANTAGONISTS AND USES THEREOF Vanqua Bio, Inc. (US) 2025-07-23 EP disclosed
WO-2024059096-A2 C5AR1 ANTAGONISTS AND USES THEREOF VANQUA BIO, INC. (US) 2024-03-21 WO disclosed